These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 34097774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
    Xu W, Tan J, Cai C, Lei L, Cao X, Zhou H, Xu M.
    Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
    [Abstract] [Full Text] [Related]

  • 10. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M.
    J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
    Kim YJ, Yang HJ, Won CH, Chang SE, Lee MW, Lee WJ.
    Dermatology; 2023 Sep; 239(5):700-711. PubMed ID: 37231869
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.
    Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, Bu W, Turk SP, Liepshutz K, Hornung RL, Fassihi H, Sarkany RP, Bonnycastle LL, Chines PS, Swift AJ, Myers TG, Levoska MA, DiGiovanna JJ, Collins FS, Kraemer KH, Pittaluga S, Jaffe ES.
    Blood; 2019 Jun 27; 133(26):2753-2764. PubMed ID: 31064750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.
    Feng X, Li F, Zhang Y, Wang L.
    Pediatr Dermatol; 2021 Sep 27; 38(5):1387-1388. PubMed ID: 34561883
    [Abstract] [Full Text] [Related]

  • 18. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
    Wen PF, Zhang M, Wang TT, Liu HJ, Zhang WY, Liu WP, Wang L.
    Am J Dermatopathol; 2019 Jan 27; 41(1):7-15. PubMed ID: 30085959
    [Abstract] [Full Text] [Related]

  • 19. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
    Chen CC, Chang KC, Medeiros LJ, Lee JY.
    J Cutan Pathol; 2016 Dec 27; 43(12):1102-1111. PubMed ID: 27531667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.